Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CD8(+) T cells in multiple sclerosis.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS.
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Headache and neurological disease in pregnancy.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: an open label study.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.

Pages